Active, Not Recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) NCT02465060 Conditions Adenocarcinoma, Adnexal Diseases, Advanced Lymphoma, +138 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States Thomas Hospital — Fairhope, Alabama, United States Mobile Infirmary Medical Center — Mobile, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States View all 1411 locations View more locations Show fewer locations Loading locations... View Trial Details
